MIDLOTHIAN, Va., March 1 Today, PARI Respiratory Equipment launched their newest aerosol delivery system, the Vios. Paired with PARI's gold standard reusable nebulizers, Vios delivers fast treatments, ...
This patent covers our drug-device combination through March 2043,” said Matt Pauls, J.D., M.B.A, Chair and Chief Executive Officer, Savara. “With 10 years of Orphan Drug regulatory exclusivity upon ...
Respiratory devicemaker PARI picked up an approval from the FDA for its eRapid nebulizer system, which is the first electronic one to deliver Genentech's cystic fibrosis treatment Pulmozyme. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback